Equifund’s Private Market Investing Workshop
Session 9: Expert Interview – Carl Allen & Adam Markley, Co-Founders of Prox Capital

By Equifund

This webinar is brought to you by Equifund Technologies, LLC.

Speakers: Jake Hoffberg & Carl Allen & Adam Markley

Duration: 49 minutes

Summary: These two individuals are changing the way small businesses are being acquired and sold.  Today, they’re sharing their secrets on how you can buy a profitable, cash flowing business for less than you think.

Guest Speaker Bio: 

Carl Allen is a private equity investor, co-founder PROX Capital Group, and co-founder of Dealmaker Wealth Society.  He is an entrepreneur, investor and corporate dealmaker with almost three decades of experience.  Over the course of his career he has enabled over 300 deals and done $47 billion in transactions.

Adam Markley is co-founder and publisher of Dealmaker Wealth Society. He is also CEO and co-founder of PROX Capital Group. In his career he has bought, owned and ran companies across a wide range of industries, touching nearly 500 businesses. He has advised and mentored deals worth millions of dollars, improved companies bottom line and built many capable, talented teams.

Download the on-screen “interview notes” for this workshop

Go here to get your copy of Carl’s latest book Zero-Down Business-Buying Secrets: How To Buy an Established, Profitable Business Using None of Your Own Money

Books Mentioned: Barbarians at the Gate: The Fall of RJR Nabisco

More Articles:

The Era of Net-Zero Mining

28 mining and metals companies commit to a goal of net-zero direct and indirect carbon emissions by 2050 or sooner

Don't make another private market investment without reading this...

The 5 Mistakes

investors make that crush returns

Download this free report now:

Just enter your name & email to access this report for free.

By submitting your email address you will receive access to this report and a free subscription to Equifund’s private investment newsletter. You can unsubscribe at any time and read more about our privacy policy here.

More Articles:

Advertisement:

Kleiner Device Labs

Investment Highlights:

  • 1

    Proprietary devices that could revolutionize spinal surgery and greatly improve success rates, reduce pain, and lower costs.

  • 2

    Over 20 patents have been issued to protect the company's technologies.

  • 3

    Just received FDA clearance for their next-generation KG2 spinal fusion technology.

Pre-Investment Agreement

The next 8 slides will allow us to process your investment. Note that these next steps are a legal requirement – Thank you for your patience and financial support of this investment opportunity. Jordan Gillissie – CEO

Before we execute the investment, it’s important for us to make sure you’re comfortable and knowledgeable in early stage investing. We want to make sure that you:

    • Received and have reviewed the education materials sent to you.
    • UNDERSTAND; that there are restrictions on your ability to cancel your investment commitment and obtain a return of your investment.
    • KNOW; It may be difficult to resell securities acquired under Regulation Crowdfunding.
    • AGREE; investing in securities offered and sold in reliance on section 4(a)(6) of the Securities Act involves risk. Investors should not invest any funds unless he or she can afford to lose the entire amount of his or her investment. Your investment may not work out, and you must be in a financial condition to bear the loss.
  • Hidden
  • Hidden
  • Hidden
  • Hidden

We are currently upgrading our system. If you click submit and the process does not continue in a few seconds, please refresh this page manually, and click Invest Now again and you should be moved on to the next step.

Complete Your Registration

By verifying your account you agree with our terms of use, privacy policy and pre-dispute arbitration agreement. Please complete the registration process by clicking the link below:

Verify Your Email

Please wait a few minutes while we create your account. An email will be sent to you shortly to confirm your admittance. Should the email be delivered to your spam or promotions folder, we recommend you move it to your inbox and mark Equifund as a safe sender.

If you have not received the email in 5 minutes, please click here to have it resent.

Questions? Our customer service team is always here to help – 1-866-338-3004

Enter your email address to get instant access to the video: